(Q45016732)

English

Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity

scientific article published on April 30, 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity (English)

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

desensitization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cancer cell line

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

author name string

C. Gespach

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6329177

30 September 2023

S. Emami

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6329177

30 September 2023

G. Rosselin

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6329177

30 September 2023

language of work or name

0 references

publication date

1 April 1984

1 reference

Europe PubMed Central

8 December 2017

30 April 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6329177

30 September 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0006291X84913044?httpAccept=text/xml

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

https://api.elsevier.com/content/article/PII:0006291X84913044?httpAccept=text/plain

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

8 December 2017

120

1 reference

Europe PubMed Central

8 December 2017

2

1 reference

Europe PubMed Central

8 December 2017

641-649

1 reference

Europe PubMed Central

8 December 2017

Regulation by vasoactive intestinal peptide of cyclic AMP accumulation in gastric epithelial glands. A characteristic of human stomach

1

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Regulation by Vasoactive Intestinal Peptide, Histamine, Somatostatin-14 and -28 of Cyclic Adenosine Monophosphate Levels in Gastric Glands Isolated from the Guinea Pig Fundus or Antrum*

2

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Differential effects of histamine, vasoactive intestinal polypeptide, prostaglandin E2 and somatostatin on cyclic AMP-dependent protein kinase activation in gastric glands isolated from the guinea pig fundus and antrum

3

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum

4

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Secretin binding sites coupled with adenylate cyclase in rat fundic membranes

5

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat

6

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems present in rat gastric glands

7

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ action

8

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1.

10

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP)

14

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide

15

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats

16

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

A Gastric Inhibitory Polypeptide II: The Complete Amino Acid Sequence

19

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Comparison of vasoactive intestinal peptide (VIP) and secretin in gastric secretion and mucosal blood flow

20

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro

22

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequence

23

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 1. Characterization, quantitative aspects and structural requirements of binding sites

29

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin

30

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Beta-adrenergic regulation of cyclic adenosine 3',5' monophosphate accumulation in human gastric epithelial glands. Inhibitory effect of somatostatin

31

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Human gastric mucosal adenylate cyclase activity: effects of various cytoprotective prostaglandins

32

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide

33

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide

34

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Bioactive enteroglucagon (oxyntomodulin): Present knowledge on its chemical structure and its biological activities

35

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Gut glucagon: A common receptor site with pancreatic glucagon in liver cell plasma membranes

36

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera.

37

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Ontogeny and distribution of immunoreactive gastric inhibitory polypeptide (IR-GIP) in rat small intestine

38

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Ontogeny of gastric inhibitory peptide in the human gastro-intestinal tract and endocrine pancreas

39

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Ontogeny of immunoreactive glicentin in the human gastrointestinal tract and endocrine pancreas

40

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Fat-induced jejunal inhibition of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide, and vasoactive intestinal polypeptide in man.

41

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Glicentin inhibits gastric acid secretion in the rat

44

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Direct inhibition of gastric acid by growth-hormone release-inhibiting hormone in dogs

46

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Forskolin stimulation of acid and pepsinogen secretion in isolated gastric glands

47

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Selective inhibition by somatostatin of cyclic AMP production in rat gastric glands: demonstration of a direct effect on the parietal cell function

48

1 reference

10.1016/0006-291X(84)91304-4

https://api.crossref.org/works/10.1016/0006-291X(84)91304-4

30 September 2023

Identifiers

10.1016/0006-291X(84)91304-4

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45016732&oldid=1984034821"